Lung cancer patients lacking MSH2 DNA repair protein fare better with chemo

Targeting death receptors in chemo-resistant cancer cells

Treatment based on rising CA125 blood levels does not improve survival for recurrent ovarian cancer

Sentinel node biopsy is effective, less invasive option for early-stage cervical cancer patients

Standard treatment plus trastuzumab for HER2+ gastric cancer

Olaparib induces tumour response as single agent in BRCA-deficient breast cancer

PARP inhibitor BS-201 plus chemotherapy: new option for triple-negative breast cancer

Therapeutic vaccine improves response rate and extends progression-free survival in patients with metastatic melanoma

Bortezomib based therapies for myeloma

Therapeutic cancer vaccine significantly prolongs disease-free survival for follicular lymphoma

PARP inhibitors show promise for hard-to-treat breast cancers

Neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients